Abe M. Chutorian, Michael Geffner> ;Revista De Neurologia. 1999 Aug 17
Abstracts/Posters
A Phase 2 Open-Label Study of Danicopan (ACH_0144471) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have an Inadequate Response to Eculizumab Monotherapy
Michael Geffner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Chutes & Ladders—Apic Brings on Solid Bio Vet Quiroz to Chief Medical RoleAugust 29, 2020 10:39
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: